Funded Tech Companies

Alys Pharmaceuticals

Alys Pharmaceuticals is a biopharmaceutical company, based in Boston. Investment was provided by Medicxi Ventures.

Company Overview

Company Name
Alys Pharmaceuticals
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
100 Northern Avenue
Boston, MA 02210
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Alys Pharmaceuticals is a pioneering force in immuno-dermatology, poised to redefine the treatment landscape with cutting-edge science and a robust R&D-centric multi-platform pipeline. Launched in February 2024, Alys emerges as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi.
Profile
Alys Pharmaceuticals LinkedIn Company Profile
Social Media
Alys Pharmaceuticals Company Twitter Account
Company News
Alys Pharmaceuticals News
Facebook
Alys Pharmaceuticals on Facebook
YouTube
Alys Pharmaceuticals on YouTube
Last Transaction
2/12/2024

Financing History

Date
Type
Amount
Venture Equity
$100,000,000


Management Team

Title
Name
Email & Social
Chief Financial Officer
Nicola De Francesco
  Nicola De Francesco LinkedIn Profile  Nicola De Francesco Twitter Account  Nicola De Francesco News  Nicola De Francesco on Facebook
Chief Medical Officer
Lars French
  Lars French LinkedIn Profile  Lars French Twitter Account  Lars French News  Lars French on Facebook
Chief Operating Officer
Thibaud Portal
  Thibaud Portal LinkedIn Profile  Thibaud Portal Twitter Account  Thibaud Portal News  Thibaud Portal on Facebook
Chief Technical Officer
John Harris
  John Harris LinkedIn Profile  John Harris Twitter Account  John Harris News  John Harris on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Alydia Health | Alysio

 

Share this article

 


About Our VC & M&A Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary